| Establishes a drug-induced movement disorder screening education program to educate the public, healthcare professionals, mental health professionals, public safety officials, and public health officials about the importance of screening for drug-induced movement disorders, develop guidance on clinical standards for treating drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions. |
